Clinical Association of White Matter Hyperintensities Localization in a Mexican Family with Spastic Paraparesis Carrying the PSEN1 A431E Mutation.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 31 12 2019
medline: 11 5 2021
entrez: 30 12 2019
Statut: ppublish

Résumé

Presenilin 1 gene (PSEN1) mutations are the most common cause of familial Alzheimer's disease (FAD). One of the most abundant FAD mutations, PSEN1 A431E, has been reported to be associated with spastic paraparesis in about half of its carriers, but the determining mechanisms of this phenotype are still unknown. In our study we characterized three A431E mutation carriers, one symptomatic and two asymptomatic, from a Mexican family with a history of spastic paraparesis in all of its affected members. At cognitive assessment and MRI, the symptomatic subject showed an atypical non-amnestic mild cognitive impairment with visuospatial deficits, olfactory dysfunction and significant parieto-occipital brain atrophy. Furthermore, we found several periventricular white matter hyperintensities whose progression pattern and localization correlated with their motor impairment, cognitive profile, and non-motor symptoms. Together, our data suggests that in this family the A431E mutation leads to a divergent neurological disorder in which cognitive deterioration was clinically exceeded by motor impairment and that it involves early glial and vascular pathological changes.

Identifiants

pubmed: 31884479
pii: JAD190978
doi: 10.3233/JAD-190978
doi:

Substances chimiques

PSEN1 protein, human 0
Presenilin-1 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1075-1083

Auteurs

Rosalía A Santos-Mandujano (RA)

Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), CDMX, México.

Natalie S Ryan (NS)

Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK.

Lucía Chávez-Gutiérrez (L)

VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium.
Department of Neurosciences, Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, Leuven, Belgium.

Carmen Sánchez-Torres (C)

Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), CDMX, México.

Marco Antonio Meraz-Ríos (MA)

Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), CDMX, México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH